©   Fund

 Global fund





 NGOs and Civil Society

 Private Sector


 Funding Proposals

 Review Process

 For Journalists

 Background Documents









 Contact Us

 Site Map


The Fund to Fight AIDS, Tuberculosis & Malaria


Press Release
25 April 2002


Commits Up to $616 Million Over Two Years for Prevention and Treatment
Calls for Additional Resources to Address World’s Deadliest Epidemics

The new Fund to Fight AIDS, Tuberculosis and Malaria today announced its first round of grants to programs to prevent and treat the three diseases in severely affected countries. The Fund awarded a total of US$378 million over two years to 40 programs in 31 countries, a significant increase in international spending to combat the diseases.

The Board also agreed a fast-track process to approve an additional US$238 million for 18 proposals in 12 countries, plus three multi-country proposals, provided certain conditions are met. This would bring the total funding over two years to US$616 million. These programs add up to US$1.6 billion over five years. Funding after the second year will be approved based on performance during the first two years.

The announcement came at the conclusion of the second meeting of the Fund’s Board, held from April 22-24 at the Mailman School of Public Health at Columbia University in New York.

Officials described the initial grants as a successful start to the Fund, an independent, public-private partnership working to increase global resources to combat diseases that kill six million people each year.

“Less than three months after the Fund issued its first call for proposals, it is directing funds where they are needed to help fight AIDS, tuberculosis, and malaria,” said Dr. Chrispus Kiyonga, chair of the Fund’s Board and Minister without Portfolio of the government of Uganda. “The Fund’s grants will provide critical support to effective prevention and treatment programs around the world.”

At the same time, Fund officials also noted that more resources are urgently needed to fight the epidemics.

“UN Secretary-General Kofi Annan has called for US$7-10 billion each year to combat HIV/AIDS alone,” said Philippa Lawson of the Academy for Educational Development (AED) and Fund Board member representing people living with or affected by one of the three diseases. “The Fund has raised more than $2 billion in less than a year.  This a successful start, but the Fund needs far more resources to fight AIDS, TB, and malaria – millions of lives are at stake.”

Strong Competition for Limited Resources

The approved grants were selected from more than 300 proposals submitted for the first round of funding. In all, these proposals requested more than US$5 billion from the Fund over five years.

All eligible proposals were thoroughly evaluated by the Fund’s Technical Review Panel, an independent group of 17 experts in prevention, clinical care, health education, and international development. Final decisions on grant awards were made by the Board.

“We received far more proposals than we are able to fund in this first round, demonstrating how great the need is to address HIV/AIDS, tuberculosis and malaria,” said Dr. Anders Nordström, Interim Executive Director of the Fund. “We prioritized high-quality proposals that were based on effective programs and lessons learned, and were developed by partnerships of governments, community organizations, people living with the diseases, and other groups.”

“We also prioritized proposals that clearly demonstrated how new resources from the Fund would fill funding gaps and achieve results,” added Dr. Nordström.

The Fund plans to issue a second call for proposals later this year. Officials noted that the Fund will continue to look for ways to make the application process as accessible as possible to potential grantees.

“We have learned a great deal from the first round of funding,” said Philippa Lawson of AED. “Since the Fund is a new mechanism designed to respond to a global crisis, it faces the challenge and the responsibility to identify and specifically solicit proposals designed to fill gaps on under-represented components – including antiretroviral treatment, and a balanced portfolio of regions, diseases and treatment.”

“The Board is committed to continually improving and streamlining the application process and helping potential grantees to submit high-quality proposals,” added Ms. Lawson.

Grants Will Support Effective Prevention and Treatment Programs Worldwide

The grants announced today will support a wide range of prevention and treatment programs for the three diseases. Most of the approved grants include both prevention and treatment components. Of the 28 countries that will receive funds to fight HIV/AIDS, 21 have grants that specifically include funding to purchase antiretroviral treatments for people living with HIV/AIDS.

“The first round of grants reflects the Fund’s strong commitment to a comprehensive approach to fighting HIV/AIDS, TB, and malaria that balances prevention and treatment,” Dr. Kiyonga said.

Dr. Kiyonga also noted that the Fund and its partners have strong monitoring and evaluation procedures in place to ensure that grant funds will be used properly and have a measurable impact.

“The Fund disburses grants with a minimum of red tape, but with safeguards to ensure that funds are used wisely and achieve results,” said Dr. Kiyonga. “We will work closely with grantees to monitor program implementation, financial management, and health outcomes.”

The 40 grants awarded today will support HIV/AIDS, TB, and malaria programs in all regions of the world, as follows: Africa 52%, Americas 13%, Eastern Mediterranean 1%, Eastern Europe and Central Asia 8%, Southeast Asia 12%, and Western Pacific 14%. About 60% of the funds granted in this round goes to projects working in HIV/AIDS, and an additional 15% goes to programs fighting HIV/AIDS combined with one or both of the other diseases. Ten percent goes to programs working to fight malaria, and 16% to programs focusing on tuberculosis.

Far More Resources Are Needed

Fund officials said today that the initial round of grants is only a first step in addressing the AIDS, TB and malaria epidemics, and that far more resources are needed to mount sufficient, effective programs of treatment and prevention for the three diseases.

“This funding is a significant advance in the global fight against AIDS, TB and malaria, but it is only a first step,” said Dr. Anne Peterson, Assistant Administrator for Health at the US Agency for International Development (USAID). “More funding is needed from governments, businesses, foundations, and other donors if we are to mount an effective and sustained response to these epidemics.”

To date, the Fund has raised approximately US$2.08 billion from industrialized and developing country governments, businesses, foundations, and individuals. The Fund supplements, but does not replace, existing national, bilateral, and multilateral donor programs.

Richard Feachem Appointed Executive Director

Fund officials also announced the appointment of Professor Richard Feachem as Executive Director of the Fund.

Dr. Feachem, a British national, is currently Founding Director of the Institute for Health, and Professor of International Health at the University of California, San Francisco and Berkeley. Prior to this position he was Director for Health, Nutrition and Population at the World Bank. From 1989 until 1995, Dr. Feachem was Dean of the London School of Hygiene and Tropical Medicine in London. He holds a Doctor of Science in Medicine and a PhD in Environmental Health.

“Professor Feachem has outstanding experience in the field of international health, and has worked with both the public and private sectors,” said Rajat Gupta, Managing Director of McKinsey & Company and Fund Board member. “We are very pleased about his selection as the Fund’s Executive Director.”

”It is a great honor for me to have the opportunity to work for the Fund," said Dr. Feachem. "The poverty and suffering caused by AIDS, tuberculosis and malaria are immense. The Fund is positioned to make large investments in controlling these terrible diseases and improving the lives of millions of families throughout the world. I look forward to contributing to the Fund's success, to leading the Secretariat, and to working with the Fund's many partners and supporters. Together we can make a difference."

Dr. Anders Nordström, Head of the Health Division of the Swedish Agency for Development Cooperation (SIDA), has been serving as the Fund’s Interim Executive Director.

About the Fund

AIDS, TB and malaria have a devastating global impact, causing nearly six million deaths a year – 10% of the world’s total. The Fund to Fight AIDS, Tuberculosis and Malaria is an independent public-private partnership working to increase funding to fight the three diseases, and direct these funds rapidly to effective prevention and treatment programs in the countries with greatest need. The Fund’s Board includes representatives of all parties that have a stake in fighting the three diseases: donor and recipient country governments, international agencies, NGOs, the private sector, and people affected by the three diseases.


Melanie Zipperer at +41 79 477 17 22

Back on top